Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC) 1Ovarian Neoplasms 1Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 280Specimen Handling 266pembrolizumab 244Cyclophosphamide 224Radiotherapy 220Nivolumab 179Cisplatin 166Biopsy 158Carboplatin 150Radiosurgery 144fludarabine 124Blood Specimen Collection 121Surveys and Questionnaires 117venetoclax 115Gemcitabine 115Paclitaxel 114Standard of Care 104Dexamethasone 103Rituximab 91Radiation 90Oxaliplatin 87Bevacizumab 87Ipilimumab 84Drug Therapy 84Cytarabine 84Doxorubicin 81durvalumab 77Capecitabine 77Fluorouracil 69fludarabine phosphate 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × FAPI-46 × 90 days × Clear all
NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated
20 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡